ArticleProceedings of the National Academy of Sciences of the United States of America2018

Site-selective chemoenzymatic glycoengineering of Fab and Fc glycans of a therapeutic antibody.

John P Giddens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.